- 全部删除
您的购物车当前为空
Fexapotide (NX-1207) TFA 可选择性诱导细胞凋亡,降低细胞层面的前列腺体积,适用于下尿路症状 (LUTS) 和良性前列腺增生 (BPH) 的研究。
Fexapotide (NX-1207) TFA 可选择性诱导细胞凋亡,降低细胞层面的前列腺体积,适用于下尿路症状 (LUTS) 和良性前列腺增生 (BPH) 的研究。

Fexapotide TFA 相关产品
| 产品描述 | Fexapotide (NX-1207) TFA selectively induces apoptosis, leading to a reduction in prostate volume at the cellular level. Fexapotide is applicable for research into lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH). |
| 别名 | NX-1207 TFA |
| 分子式 | C90H163N27O25S.xC2HF3O2 |
| 存储 | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容